Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
about
A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future ProspectsIncreased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell ImagingFocus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic SystemsStem cell transplantation therapy in Parkinson's diseaseMesenchymal stem cells for the treatment of neurodegenerative and psychiatric disordersMultipotent progenitor cells derived from adult peripheral blood of swine have high neurogenic potential in vitro.Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the artMesenchymal stem cells for the treatment of neurodegenerative disease.Dopamine release from transplanted neural stem cells in Parkinsonian rat striatum in vivo.Prenatal exposure to methylphenidate affects the dopamine system and the reactivity to natural reward in adulthood in rats.Phenotypic changes in cultured smooth muscle cells: limitation or opportunity for tissue engineering of hollow organs?Critical aspects of clinical trial design for novel cell and gene therapies.Parkinson's disease and mesenchymal stem cells: potential for cell-based therapyIntracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.Kinetics of thermally induced heat shock protein 27 and 70 expression by bone marrow-derived mesenchymal stem cells.Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.Updates in the pathophysiological mechanisms of Parkinson's disease: Emerging role of bone marrow mesenchymal stem cellsTransplantation of Deprenyl-Induced Tyrosine Hydroxylase-Positive Cells Improves 6-OHDA-Lesion Rat Model of Parkinson's Disease: Behavioral and Immunohistochemical Evaluation.Cell based therapy in ParkinsonismCellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's diseaseCell-based therapies for Parkinson's disease.Autologous stem cells in neurology: is there a future?Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system.Biodistribution of mesenchymal stem/stromal cells in a preclinical setting.Preconditioning as a potential strategy for the prevention of Parkinson's disease.The Secretome of Bone Marrow and Wharton Jelly Derived Mesenchymal Stem Cells Induces Differentiation and Neurite Outgrowth in SH-SY5Y Cells.Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.Differentiation of Wharton's Jelly-Derived Mesenchymal Stem Cells into Motor Neuron-Like Cells on Three-Dimensional Collagen-Grafted Nanofibers.Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells.Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's disease.Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.Stem cell transplantation for treating Parkinson's disease: Literature analysis based on the Web of Science.Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT.Neuroprotective Surgical Strategies in Parkinson's Disease: Role of Preclinical Data.Survival and immunogenicity of mesenchymal stem cells from the green fluorescent protein transgenic rat in the adult rat brain.Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases.
P2860
Q26746033-4DA0D159-8DD8-487B-83CC-3D191CBF5C15Q26753150-02F4E6A6-ECEE-4A8B-8167-B73FC25A1B63Q26767267-1A475A1C-07E4-46DD-93A7-848FE7899B9DQ26778682-62238239-822C-40BF-AA99-C4BA0BC0CE6DQ26801575-2DA33901-EABB-48D9-99F4-CA1CDE684221Q30503659-4D5A2AA2-6676-495E-B029-1091C091FDDBQ33564990-FFE2FEB6-4E96-4D5D-89B5-590C3536F4BAQ33722420-1CD7D87F-587C-408F-9761-FE13EACABBDEQ33916202-1D34F9C8-2DDC-40DA-B761-095911111564Q34271229-121A3A9F-0AD9-43EE-AAD8-75E30A9B9B01Q34473474-FF06A6C5-39F1-4DFC-B4BC-29F44EFA2CDEQ34480963-AD956CE6-30EA-4970-824F-F488C3FC50ECQ35179006-1395AB1B-151D-44CE-9F54-4EB39C043A59Q35612819-31036872-43CB-4815-8D0A-6D9DE6500B01Q35664438-C38D0C28-C428-444C-BB7F-BD4FF257917FQ35864178-57F9AA53-848E-4D98-B589-B7D998E656A2Q35975405-60AB05CD-47BB-49ED-AB2A-8CD764CCFFC7Q36111475-2E521796-27E0-485A-A549-AE411796EF6BQ36419634-DD238C14-0952-4271-9A19-C40C0F3C6FEBQ36727515-0DD6FF8B-B081-4CE8-9AAB-A17458FD5530Q36862636-AFE61BC0-E005-48DC-BCF6-FD8633EB9405Q36908657-CE162831-F9EC-4FED-A6D8-BD293A21E920Q37236894-1F9FE4AA-FCDA-41B7-8F17-6795BBA96BC7Q37886149-44F54820-BC4B-42A6-835E-9A5D54E5B102Q38062482-234682E0-3061-42DC-A218-3C358A261E2AQ38086083-A32AA4F6-9BA9-4B7C-8FA4-C555D066C0DEQ38098448-4EC0C5C8-73A5-47AA-8307-CDDCA7BD8876Q38162182-72EED44F-94D8-4AAD-BC70-73E8C1D3948DQ38201685-63E295FE-14C1-453B-A7D2-8D4975F13217Q38964971-3541697D-C804-4BB2-8D71-BF6309D14CCCQ38999345-B255198A-209D-426D-8186-1CABF0A14774Q39003538-67752F37-B9A2-4498-A747-F1DE20D6BBC2Q39190753-94459860-8314-464C-BEB4-547004F5A251Q39368017-2D366E07-BF44-4D78-9CE7-09509AACEF93Q39792829-072C2987-1B82-4272-AD69-9A6E617A187DQ41360983-E79A2D5B-B529-4E1C-8BDF-C3020D5208CFQ42470263-032C0563-1AA7-41B6-BF07-0C1DF6533197Q44266420-64AE6994-60F8-4CD4-8B94-F6433934AD51Q44545162-E8A7107E-D787-4E04-840A-F6A7CD194A74Q47941437-588DA738-1E7C-41E8-8FAB-212E7BBCF4DC
P2860
Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Partial recovery of dopaminerg ...... model of Parkinson's disease.
@en
Partial recovery of dopaminerg ...... model of Parkinson's disease.
@nl
type
label
Partial recovery of dopaminerg ...... model of Parkinson's disease.
@en
Partial recovery of dopaminerg ...... model of Parkinson's disease.
@nl
prefLabel
Partial recovery of dopaminerg ...... model of Parkinson's disease.
@en
Partial recovery of dopaminerg ...... model of Parkinson's disease.
@nl
P2093
P1476
Partial recovery of dopaminerg ...... model of Parkinson's disease.
@en
P2093
Angélique Rico
Gaëlle Bouchez
Jean-Claude Besnard
Luc Sensebé
Lucette Garreau
Patrick Vourc'h
Pierre Charbord
Sylvie Bodard
P304
P356
10.1016/J.NEUINT.2008.02.003
P577
2008-03-10T00:00:00Z